UBS’s Innoviva INVA Stock Holding History

UBS’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-124	Closed	-$4K	–	10520
2013 Q2	$4K	Buy	+124	New	+$3.33K	﹤0.01%	9412

Other funds holding INVA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return

UBS's INVA Position: Q3 2014 in Review

UBS reduced its Innoviva (INVA) stake by 87% in Q3 2014, selling an estimated $634K and leaving 4,132 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #6405.

UBS first reported a position in INVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.87M in Q4 2013. 120 funds tracked by Wall St. Rank hold INVA as of Q3 2014.

UBS held 4,132 shares of Innoviva worth $71K as of Q3 2014.
UBS sold 27,585 Innoviva shares in Q3 2014, an estimated $634K.
Innoviva made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6405 holding.
UBS first reported a position in Innoviva in Q2 2013 and has held it in 6 quarters since.
UBS's Innoviva position peaked at $1.87M in Q4 2013.
120 funds tracked by Wall St. Rank held Innoviva as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.